Antibody, Drug Trials and Licensing - Clinical Research Informer

GSK suffers another R&D setback, axing ulcerative colitis drug trial

pharmaphorum

JANUARY 25, 2021

GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week. The post GSK suffers another R&D setback, axing ulcerative colitis drug trial appeared first on.

Drug Trials

Drug Trials Trials Drugs Licensing

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

XTalks

APRIL 26, 2021

It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Children have been the focus of malaria vaccine and drug trials because over 90 percent of deaths attributable to malaria are in African children under the age of five.

Vaccination

Vaccination Vaccine Immune Response Trials

Clinical Research Informer

GSK suffers another R&D setback, axing ulcerative colitis drug trial

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

Webinars

Stay Connected